{
    "nctId": "NCT02785887",
    "briefTitle": "Impact of Geriatrician Interventions on Chemotherapy Delivery in Vulnerable Elderly Oncology Patients",
    "officialTitle": "Impact of Geriatrician-implemented Interventions on Chemotherapy Delivery in Vulnerable Elderly Patients With Early or Metastatic Solid Malignancies: the GIVE Trial",
    "overallStatus": "COMPLETED",
    "conditions": "Breast Cancer, Lung Cancer, Ovarian Cancer, Prostate Cancer, Bladder Cancer, Gastrointestinal Cancer",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "RANDOMIZED",
    "primaryPurpose": "HEALTH_SERVICES_RESEARCH",
    "enrollmentCount": 233,
    "primaryOutcomeMeasure": "Relative dose intensity",
    "eligibilityCriteria": "Inclusion Criteria:\n\n1. Any solid tumors\n2. Either early stage disease planned for treatment with neo/adjuvant chemotherapy, or metastatic disease planned for treatment with chemotherapy and \u2264 1 previous chemotherapy treatment in the metastatic setting\n3. Absence of symptomatic central nervous system (CNS) metastases\n4. Eastern Cooperative Oncology group (ECOG) performance status 0-2\n5. Estimated life expectancy of \u2265 12 weeks\n6. At least 1 deficit identified on CGA at screening/baseline, and/or at least one comorbidity of grade 3 or 4 severity, as defined by CIRS-G\n7. Written informed consent in according to International Conference on Harmonisation of technical requirements for registration of pharmaceuticals for human use/Good Clinical Practice (ICH/GCP), and national/local ethics regulations\n8. Absence of any psychological, familial, sociological or geographical condition potentially hampering compliance with the trial protocol and follow-up schedule\n\nExclusion Criteria:\n\n1. Age \u2264 69 years\n2. Any patients who did not meet the inclusion criteria",
    "sex": "ALL",
    "minimumAge": "70 Years",
    "stdAges": "OLDER_ADULT"
}